ANOSMIA AND HOSPITALISATION IN COVID19 - A RETROSPECTIVE STUDY IN BBMP CCC
DOI:
https://doi.org/10.48047/Keywords:
COVID-19, Anosmia, Hospitalization rates, Prognostic marker, Disease progressionAbstract
Background
COVID-19, characterized by a range of symptoms including fever, myalgia, and respiratory distress, has presented varying hospitalization rates globally. This study sought to investigate the correlation between anosmia and hospitalization rates among COVID-19 patients.
Methods
A retrospective study involving 2698 patients (1698 male, 1000 female; mean age 33
years) was conducted. Data on symptoms presentation and hospitalization rates were
collected and analyzed.
Results
A significant portion of the study population exhibited anosmia (62%) and ageusia (31%). Remarkably, none of the patients presenting with anosmia required hospitalization, contrasting with a 9.37% hospitalization rate among non-anosmic patients. The symptomatic profile, dominated by fever (90%), myalgia (80%), and headache (72%), aligned with previous studies.
Conclusion
Our study underscores a potential protective role of anosmia against severe COVID19 progression, as evidenced by the lower hospitalization rates among this group. These findings advocate for further research to explore the underlying biological mechanisms and to evaluate anosmia as a potential prognostic marker for milder disease progression in COVID-19 patients.
